Precision BioSciences, Inc(NASDAQ:DTIL) 
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company operates through two segments, Therapeutic and Food. It offers ARCUS, a genome editing platform to cure genetic disorders. The Therapeutic segment develops allogeneic CAR T immunoth...
Website: http://precisionbiosciences.com/
Founded: 2006
CEO: Matthew Kane
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 4.54
H 4.71
L 4.48
C 4.61
V 178,135
10EMA 4.61
20EMA 4.61
60EMA 4.61
120EMA 4.61
250EMA 4.61